Electronic reminders to encourage older adults in Denmark to get vaccinated against flu may have unintentionally lowered ...

Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. The French pharma in April joined forces with the UK ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

Starting this year, pharma giant Sanofi SNY markets Novavax’s COVID-19 vaccine and is also using it to develop novel COVID-19-influenza combination vaccines. Per the deal terms between the ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

Sinovac Biotech, a China-based biopharmaceutical company specializing in vaccine development, has been urged by shareholder ...

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health agencies under Robert F. Kennedy Jr.’s leadership.

By Christy Santhosh (Reuters) -Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi for COVID-19 vaccines to generate ...

The COVID-19 vaccine maker reported an earning loss of ... Since Novavax is reliant on Sanofi’s sales forecasts for certain revenue components, these will not be included in the 2025 Revenue ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...